Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.5 EUR | +0.61% |
|
-0.60% | +96.43% |
03:21pm | Dpa-AFX Overview: COMPANIES from 20/06/2024 - 15:15 | DP |
11:10am | Novartis: towards the filing of a buyout offer for MorphoSys | CF |
Evolution of the average Target Price on MorphoSys AG
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering MorphoSys AG
UBS | |
JPMORGAN | James Gordon |
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
GOLDMAN SACHS | Rajan Sharma |
Wells Fargo Securities | |
JPMorgan Chase | |
MORGAN STANLEY | James Quigley |
BERENBERG | Xian Deng |
DEUTSCHE BANK | Rajan Sharma |
BARCLAYS | Brian Balchin |
Deutsche Bank Securities | |
Commerzbank | |
STIFEL | Marcus Wieprecht |
SVB Leerink | |
Bryan, Garnier & Co. | |
INDEPENDENT RESEARCH | Tobias Gottschalt |
RBC | Charles Weston |
HSBC | Julie Mead |
EPS Revisions
- Stock Market
- Equities
- MOR Stock
- MOR2 Stock
- Consensus MorphoSys AG